Clinical Trials · NCT04154072
A Clinical Study of NLY01 in Patient's With Early Parkinson's Disease
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Neuraly, Inc.
- Enrollment
- 255
- Start date
- Feb 2020
- Locations
- 61 sites, United States, Canada
- Primary endpoint
- Change in Unified Parkinson's Disease Rating Scale in combined score of Parts II and III from baseline to 36 weeks